1. Home
  2. MXCT vs YOOV Comparison

MXCT vs YOOV Comparison

Compare MXCT & YOOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.11

Market Cap

136.0M

Sector

Health Care

ML Signal

HOLD

Logo Concorde International Group Ltd Class A Ordinary Shares

YOOV

Concorde International Group Ltd Class A Ordinary Shares

N/A

Current Price

$0.50

Market Cap

158.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
MXCT
YOOV
Founded
1999
N/A
Country
United States
Singapore
Employees
N/A
109
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
136.0M
158.7M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
MXCT
YOOV
Price
$1.11
$0.50
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
1.7M
3.3M
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,026,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$18.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.36
52 Week High
$2.31
$1.11

Technical Indicators

Market Signals
Indicator
MXCT
YOOV
Relative Strength Index (RSI) 38.61 49.98
Support Level $1.08 $0.44
Resistance Level $1.16 $0.79
Average True Range (ATR) 0.09 0.16
MACD -0.03 -0.02
Stochastic Oscillator 6.10 18.65

Price Performance

Historical Comparison
MXCT
YOOV

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About YOOV Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. The Majority revenue is generated from Security Services.

Share on Social Networks: